Top

Published in:

01-12-2009 | Editorial

Growing evidence that radionuclide imaging identifies management strategies that improve outcome

Author: Michael R. Freeman, MD

Published in: Journal of Nuclear Cardiology | Issue 6/2009

Excerpt

In a policy statement published in 20051 concerning cost effectiveness the authors concluded that ‘the results consistently note significant cost savings when single photon emission computerized tomography (SPECT) is used as a gatekeeper by limiting angiography to only patients with provocable ischemia.’ Significant additional studies since this statement confirm and extend the value of SPECT and other radionuclide imaging studies in directing management strategies in patients with known and suspected coronary artery disease with concurrent improvement in outcome. …

Des Pres RD, Shaw LJ, Gillespie RL, Jaber WA, Noble GL, Soman P, et al. Cost-effectiveness of myocardial perfusion imaging: A summary of the currently available literature. J Nucl Cardiol 2005;12:750-9.CrossRef

Al-Housini MB, Hutchings F, Dalby M, et al. Does myocardial perfusion scintigraphy predict improvement in symptoms and exercise capacity following successful elective percutaneous coronary intervention? J Nucl Cardiol 2009. doi:10.1007/s12350-009-9112-y.

Hachamovitch R, Hayes S, Freidman JD, Cohen I, Berman DS. Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation 2003;107:2900-6.CrossRefPubMed

Shaw LJ, Hachamovitch R, Berman DS, et al. The economic consequences of available diagnostic and prognostic strategies for the evaluation of stable angina patients: An observational assessment of the value of precatheterization ischemia. J Am Coll Cardiol 1999;33:661-9.CrossRefPubMed

Haynes AB, Weiser TG, Berry WR, et al. A surgical safety checklist to reduce morbidity and mortality in a global population. N Engl J Med 2009;360:491-9.CrossRefPubMed

Boden WE, O’Rourke RA, Teo KK, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 2007;356:1503-16.CrossRefPubMed

Shaw LJ, Berman DS, Maron DJ, Mancini GBJ, et al. Optimal medical therapy with or without PCI to reduce ischemic burden: Results from the clinical outcomes utilizing revascularization and aggressive drug evaluation (COURAGE) trial nuclear substudy. Circulation 2008;117:1283-91.CrossRefPubMed

The BARI 2D Study Group. A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med 2009;360:2503-15.CrossRef

Tonino PAL, De Bruyne B, Pijls NH, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary angiography. N Engl J Med 2009;360:213-24.CrossRefPubMed

10.

Pijls NH, De Bruyne B, Peels K, et al. Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. N Engl J Med 1996;334:1703-8.CrossRefPubMed

11.

Cannon CP, Weintraub WS, Demopoulos LA, et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 2001;344:1879-87.CrossRefPubMed

12.

Marmur JD, Freeman MR, Langer A, Armstrong PW. Prognosis in medically stabilized unstable angina: Early Holter ST-segment monitoring compared with predischarge exercise thallium tomography. Ann Intern Med 1990;113:575-9.PubMed

13.

Mahmarian JJ, Dakik HA, Filipchuk NG, Shaw LJ, et al. An initial strategy of intensive medical therapy is comparable to that of coronary revascularization for suppression of scintigraphic ischemia in high-risk but stable survivors of acute myocardial infarction. J Am Coll Cardiol 2006;48:2458-67.CrossRefPubMed

14.

Beanlands RSB, Nichol G, Huszti E, Humen D, et al. F-18-Fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease. J Am Coll Cardiol 2007;50:2002-12.CrossRefPubMed

15.

Poldermans D, Schouten O, Vidakovic R, Bax JJ, et al. A clinical randomized trial to evaluate the safety of a noninvasive approach in high-risk patients undergoing major vascular surgery: The DECREASE-V pilot study. J Am Coll Cardiol 2007;49:1763-9.CrossRefPubMed

16.

Young LH, Wackers FJT, Chyun DA, et al. Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: The DIAD study: A randomized controlled trial. JAMA 2009;301:1547-55.CrossRefPubMed

Title: Growing evidence that radionuclide imaging identifies management strategies that improve outcome
Author: Michael R. Freeman, MD
Publication date: 01-12-2009
Publisher: Springer-Verlag
Published in: Journal of Nuclear Cardiology / Issue 6/2009
Print ISSN: 1071-3581
Electronic ISSN: 1532-6551
DOI: https://doi.org/10.1007/s12350-009-9120-y

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Growing evidence that radionuclide imaging identifies management strategies that improve outcome

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 6/2009

Use of phase analysis of gated SPECT perfusion imaging to quantify dyssynchrony in patients with mild-to-moderate left ventricular dysfunction

Will cardiac positron emission tomography ultimately replace SPECT for myocardial perfusion imaging?

Prognosis and coronary computed tomographic angiography: Current and emerging concepts

Is more imaging better than less?

Imaging synchrony

Does myocardial perfusion scintigraphy predict improvement in symptoms and exercise capacity following successful elective percutaneous coronary intervention?